Common Stock, Shares, Outstanding of OptimizeRx Corp from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
OptimizeRx Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • OptimizeRx Corp Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 18,759,589, a 1.7% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

OptimizeRx Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 18,759,589 +306,289 +1.7% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 18,592,442 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 18,555,991 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 18,492,789 +312,307 +1.7% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 18,453,300 +295,018 +1.6% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q1 2024 18,180,482 +22,200 +0.12% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 18,158,282 -130,289 -0.71% 31 Dec 2023 10-Q 15 Aug 2024 2024 Q2
Q3 2023 18,386,920 +125,681 +0.69% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 18,376,771 +202,589 +1.1% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 18,158,282 +255,674 +1.4% 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 18,288,571 +427,596 +2.4% 31 Dec 2022 10-Q 14 Nov 2023 2023 Q3
Q3 2022 18,261,239 +533,470 +3% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 18,174,182 +678,753 +3.9% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 17,902,608 +642,020 +3.7% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 17,860,975 +2,637,635 +17% 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q3 2021 17,727,769 +2,655,543 +18% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 17,495,429 +2,742,829 +19% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 17,260,588 +2,613,841 +18% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 15,223,340 +613,761 +4.2% 31 Dec 2020 10-K/A 10 Mar 2023 2021 FY
Q3 2020 15,072,226 +898,376 +6.3% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 14,752,600 +635,861 +4.5% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 14,646,747 +2,367,914 +19% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 14,609,579 +2,570,961 +21% 31 Dec 2019 10-K 08 Mar 2021 2020 FY
Q3 2019 14,173,850 +2,202,874 +18% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 14,116,739 +2,559,881 +22% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 12,278,833 -17,357,998 -59% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 12,038,618 +2,265,924 +23% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 11,970,976 -17,304,141 -59% 30 Sep 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 11,556,858 -17,699,509 -60% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 29,636,831 -100,786 -0.34% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 9,772,694 -19,946,173 -67% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 29,275,117 -397,015 -1.3% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 29,256,367 -6,577 -0.02% 30 Jun 2017 10-Q 01 Aug 2017 2017 Q2
Q1 2017 29,737,617 +694,192 +2.4% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 29,718,867 +687,942 +2.4% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 29,672,132 +653,707 +2.3% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 29,262,944 +6,313,125 +28% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 29,043,425 +6,118,606 +27% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 29,030,925 +6,163,606 +27% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 29,018,425 +5,656,048 +24% 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 22,949,819 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 22,924,819 31 Mar 2015 10-Q 14 May 2015 2015 Q1
Q4 2014 22,867,319 +8,049,823 +54% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 23,362,377 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q4 2013 14,817,496 31 Dec 2013 10-K 16 Sep 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.